Table of Contents

1 Study Coverage

• 1.1 Atazanavir Product
• 1.2 Market Segments
• 1.3 Key Manufacturers Covered
• 1.4 Market by Type
  • 1.4.1 Global Atazanavir Market Size Growth Rate by Product
  • 1.4.2 150 mg capsule
  • 1.4.3 200 mg capsule
  • 1.4.4 300 mg capsule
  • 1.4.5 50 mg oral powder packet
• 1.5 Market by End User
  • 1.5.1 Global Atazanavir Market Size Growth Rate by End User
  • 1.5.2 Adults
  • 1.5.3 Children 3 months of age and older
• 1.6 Study Objectives
• 1.7 Years Considered

2 Executive Summary

• 2.1 Global Atazanavir Market Size
  • 2.1.1 Global Atazanavir Revenue 2014-2025
  • 2.1.2 Global Atazanavir Sales 2014-2025
• 2.2 Atazanavir Growth Rate by Regions
  • 2.2.1 Global Atazanavir Sales by Regions
  • 2.2.2 Global Atazanavir Revenue by Regions

3 Breakdown Data by Manufacturers

• 3.1 Atazanavir Sales by Manufacturers
  • 3.1.1 Atazanavir Sales by Manufacturers
  • 3.1.2 Atazanavir Sales Market Share by Manufacturers
  • 3.1.3 Global Atazanavir Market Concentration Ratio (CR5 and HHI)
• 3.2 Atazanavir Revenue by Manufacturers
  • 3.2.1 Atazanavir Revenue by Manufacturers (2014-2019)
  • 3.2.2 Atazanavir Revenue Share by Manufacturers (2014-2019)
• 3.3 Atazanavir Price by Manufacturers
• 3.4 Atazanavir Manufacturing Base Distribution, Product Types
  • 3.4.1 Atazanavir Manufacturers Manufacturing Base Distribution, Headquarters
  • 3.4.2 Manufacturers Atazanavir Product Type
  • 3.4.3 Date of International Manufacturers Enter into Atazanavir Market
• 3.5 Manufacturers Mergers & Acquisitions, Expansion Plans

4 Breakdown Data by Product

• 4.1 Global Atazanavir Sales by Product
• 4.2 Global Atazanavir Revenue by Product
• 4.3 Atazanavir Price by Product

5 Breakdown Data by End User

• 5.1 Overview
• 5.2 Global Atazanavir Breakdown Data by End User

6 North America

• 6.1 North America Atazanavir by Countries
  • 6.1.1 North America Atazanavir Sales by Countries
  • 6.1.2 North America Atazanavir Revenue by Countries
  • 6.1.3 United States
  • 6.1.4 Canada
  • 6.1.5 Mexico
• 6.2 North America Atazanavir by Product
• 6.3 North America Atazanavir by End User

7 Europe

• 7.1 Europe Atazanavir by Countries
  • 7.1.1 Europe Atazanavir Sales by Countries
  • 7.1.2 Europe Atazanavir Revenue by Countries
  • 7.1.3 Germany
  • 7.1.4 France
  • 7.1.5 UK
  • 7.1.6 Italy
  • 7.1.7 Russia
• 7.2 Europe Atazanavir by Product
• 7.3 Europe Atazanavir by End User

8 Asia Pacific

• 8.1 Asia Pacific Atazanavir by Countries
  • 8.1.1 Asia Pacific Atazanavir Sales by Countries
  • 8.1.2 Asia Pacific Atazanavir Revenue by Countries
  • 8.1.3 China
  • 8.1.4 Japan
  • 8.1.5 Korea
  • 8.1.6 India
  • 8.1.7 Australia
  • 8.1.8 Indonesia
  • 8.1.9 Malaysia
  • 8.1.10 Philippines
  • 8.1.11 Thailand
  • 8.1.12 Vietnam
  • 8.1.13 Singapore
• 8.2 Asia Pacific Atazanavir by Product
• 8.3 Asia Pacific Atazanavir by End User

9 Central & South America

• 9.1 Central & South America Atazanavir by Countries
  • 9.1.1 Central & South America Atazanavir Sales by Countries
  • 9.1.2 Central & South America Atazanavir Revenue by Countries
  • 9.1.3 Brazil
• 9.2 Central & South America Atazanavir by Product
• 9.3 Central & South America Atazanavir by End User

10 Middle East and Africa

• 10.1 Middle East and Africa Atazanavir by Countries
  • 10.1.1 Middle East and Africa Atazanavir Sales by Countries
  • 10.1.2 Middle East and Africa Atazanavir Revenue by Countries
  • 10.1.3 GCC Countries
  • 10.1.4 Turkey
  • 10.1.5 Egypt
  • 10.1.6 South Africa
• 10.2 Middle East and Africa Atazanavir by Product
• 10.3 Middle East and Africa Atazanavir by End User

11 Company Profiles

• 11.1 Bristol-Myers Squibb
  • 11.1.1 Bristol-Myers Squibb Company Details
  • 11.1.2 Company Business Overview
  • 11.1.3 Bristol-Myers Squibb Atazanavir Sales, Revenue and Gross Margin (2014-2019)
  • 11.1.4 Bristol-Myers Squibb Atazanavir Products Offered
  • 11.1.5 Bristol-Myers Squibb Recent Development
• 11.2 TEVA
  • 11.2.1 TEVA Company Details
  • 11.2.2 Company Business Overview
  • 11.2.3 TEVA Atazanavir Sales, Revenue and Gross Margin (2014-2019)
  • 11.2.4 TEVA Atazanavir Products Offered
  • 11.2.5 TEVA Recent Development
• 11.3 Cipla
  • 11.3.1 Cipla Company Details
  • 11.3.2 Company Business Overview
  • 11.3.3 Cipla Atazanavir Sales, Revenue and Gross Margin (2014-2019)
  • 11.3.4 Cipla Atazanavir Products Offered
  • 11.3.5 Cipla Recent Development
• 11.4 Mylan
  • 11.4.1 Mylan Company Details
  • 11.4.2 Company Business Overview
  • 11.4.3 Mylan Atazanavir Sales, Revenue and Gross Margin (2014-2019)
  • 11.4.4 Mylan Atazanavir Products Offered
  • 11.4.5 Mylan Recent Development
• 11.5 Aurobindo Pharma
  • 11.5.1 Aurobindo Pharma Company Details
  • 11.5.2 Company Business Overview
  • 11.5.3 Aurobindo Pharma Atazanavir Sales, Revenue and Gross Margin (2014-2019)
  • 11.5.4 Aurobindo Pharma Atazanavir Products Offered
  • 11.5.5 Aurobindo Pharma Recent Development
• 11.6 Emcure
  • 11.6.1 Emcure Company Details
  • 11.6.2 Company Business Overview
  • 11.6.3 Emcure Atazanavir Sales, Revenue and Gross Margin (2014-2019)
  • 11.6.4 Emcure Atazanavir Products Offered
  • 11.6.5 Emcure Recent Development

12 Future Forecast

• 12.1 Atazanavir Market Forecast by Regions
  • 12.1.1 Global Atazanavir Sales Forecast by Regions 2019-2025
  • 12.1.2 Global Atazanavir Revenue Forecast by Regions 2019-2025
• 12.2 Atazanavir Market Forecast by Product
  • 12.2.1 Global Atazanavir Sales Forecast by Product 2019-2025
  • 12.2.2 Global Atazanavir Revenue Forecast by Product 2019-2025
• 12.3 Atazanavir Market Forecast by End User
• 12.4 North America Atazanavir Forecast
• 12.5 Europe Atazanavir Forecast
• 12.6 Asia Pacific Atazanavir Forecast
• 12.7 Central & South America Atazanavir Forecast
• 12.8 Middle East and Africa Atazanavir Forecast

13 Market Opportunities, Challenges, Risks and Influences Factors Analysis

• 13.1 Market Opportunities and Drivers
• 13.2 Market Challenges
• 13.3 Market Risks/Restraints
• 13.4 Macroscopic Indicators

14 Value Chain and Sales Channels Analysis

• 14.1 Value Chain Analysis
• 14.2 Atazanavir Customers
• 14.3 Sales Channels Analysis
  • 14.3.1 Sales Channels
  • 14.3.2 Distributors

15 Research Findings and Conclusion

16 Appendix

• 16.1 Research Methodology
  • 16.1.1 Methodology/Research Approach
  • 16.1.2 Data Source
• 16.2 Author Details

Atazanavir, sold under the trade name Reyataz among others, is an antiretroviral medication used to treat and prevent HIV/AIDS. It is generally recommended for use with other antiretrovirals. It may be used for prevention after a needlestick injury or other potential exposure. It is taken by mouth once a day.
The global Atazanavir market is valued at xx million US$ in 2018 and will reach xx million US$ by the end of 2025, growing at a CAGR of xx% during 2019-2025. The objectives of this study are to define, segment, and project the size of the Atazanavir market based on company, product type, end user and key regions.

This report studies the global market size of Atazanavir in key regions like North America, Europe, Asia Pacific, Central & South America and Middle East & Africa, focuses on the consumption of Atazanavir in these regions.
This research report categorizes the global Atazanavir market by top players/brands, region, type and end user. This report also studies the global Atazanavir market status, competition landscape, market share, growth rate, future trends, market drivers, opportunities and challenges, sales channels and distributors.

The following manufacturers are covered in this report, with sales, revenue, market share for each company:
Bristol-Myers Squibb
TEVA
Cipla
Mylan
Aurobindo Pharma
Emcure

Market size by Product
150 mg capsule
200 mg capsule
300 mg capsule
50 mg oral powder packet
Market size by End User
Adults
Children 3 months of age and older

Market size by Region
North America
United States
Canada
Mexico
Asia-Pacific
China
India
Japan
South Korea
Australia
Indonesia
Singapore
Malaysia
Philippines
Thailand
Vietnam
Europe
Germany
France
UK
Italy
Spain
Russia
Central & South America
Brazil
Rest of Central & South America
Middle East & Africa
GCC Countries
Turkey
Egypt
South Africa

The study objectives of this report are:
To study and analyze the global Atazanavir market size (value & volume) by company, key regions, products and end user, breakdown data from 2014 to 2018, and forecast to 2025.
To understand the structure of Atazanavir market by identifying its various subsegments.
To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
Focuses on the key global Atazanavir companies, to define, describe and analyze the sales volume, value, market share, market competition landscape and recent development.
To project the value and sales volume of Atazanavir submarkets, with respect to key regions.
To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

In this study, the years considered to estimate the market size of Atazanavir are as follows:
History Year: 2014-2018
Base Year: 2018
Estimated Year: 2019
Forecast Year 2019 to 2025

This report includes the estimation of market size for value (million US$) and volume (K Units). Both top-down and bottom-up approaches have been used to estimate and validate the market size of Atazanavir market, to estimate the size of various other dependent submarkets in the overall market. Key players in the market have been identified through secondary research, and their market shares have been determined through primary and secondary research. All percentage shares, splits, and breakdowns have been determined using secondary sources and verified primary sources.

For the data information by region, company, type and application, 2018 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.